Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition-Reference-Cited by-同舟云学术

Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition

Published:2020-06-18 Issue:1 Volume:13 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Xiao Xinhua,Liu Ping,Li Donghe,Xia Zhizhou,Wang Peihong,Zhang Xiuli,Liu Mingzhu,Liao Lujian,Jiao Bo,Ren Ruibao

Funder

National key research and development program

the Key Project of Natural Science Foundation of China

Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research

Natural Science Foundation of China

the Samuel Waxman Cancer Research Foundation

Innovative research team of high-level local universities in Shanghai

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-020-00912-3.pdf

Reference39 articles.

1. Teachey DT, Pui CH. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol. 2019;20:e142–54.

2. Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343–56.

3. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408–17.

4. Arico M, Schrappe M, Hunger SP, Carroll WL, Conter V, Galimberti S, Manabe A, Saha V, Baruchel A, Vettenranta K, et al. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol. 2010;28:4755–61.

5. Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R, Cortes J, O’Brien S, Nicaise C, Bleickardt E, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med. 2006;354:2531–41.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Pluripotency Transcription Factors in Chronic Myeloid Leukemia: Comparative Efficacy of 6-Phenylimidazo[2,1-B][1,3,4]Thiadiazole Derivative and Imatinib in K562 Cells;2024

2. GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia;Cancer Cell International;2023-11-30

3. GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia;2023-07-26

4. The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia;Genes;2023-03-10

5. BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists;Journal of Translational Medicine;2023-02-10